CORONAUpdated 7 Sept 2026, 19:23

Corona Remedies Limited

CORONAUpdated 7 Sept 2026, 19:23

Market Cap

₹12,670Cr.

Current Price

₹2,071

High / Low

₹2,270/1,337

Stock P/E

59.8

Book Value₹122

Dividend Yield0.48%

ROCE33.3%

ROE29.5%

Face Value₹10.0

About

Incorporated in August 2004, Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women’s healthcare, cardiology, pain management, urology, and other therapeutic areas.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	95	105	131	44	36	36	36	38
Inventory Days	69	52	77	184	182	158	200	175
Days Payable	126	110	182	211	163	184	221	206
Cash Conversion Cycle	38	48	27	17	55	10	14	7
Working Capital Days	67	81	86	16	30	-2	9	-15
ROCE %	—	30%	27%	1%	29%	25%	31%	33%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 7 September 2026 at 19:23

CORONA REMEDIES LIMITED (CORONA) financials — quarterly results, P&L, cash flow, balance sheet, shareholding